Switch to:

10x Genomics Accounts Payable & Accrued Expense

: $28.5 Mil (As of Mar. 2020)
View and export this data going back to 2019. Start your Free Trial

10x Genomics's quarterly accounts payable & accrued expense increased from Sep. 2019 ($24.3 Mil) to Dec. 2019 ($31.8 Mil) but then declined from Dec. 2019 ($31.8 Mil) to Mar. 2020 ($28.5 Mil).

10x Genomics's annual accounts payable & accrued expense increased from Dec. 2017 ($10.1 Mil) to Dec. 2018 ($14.6 Mil) and increased from Dec. 2018 ($14.6 Mil) to Dec. 2019 ($31.8 Mil).


10x Genomics Accounts Payable & Accrued Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

10x Genomics Annual Data
Dec17 Dec18 Dec19
Accounts Payable & Accrued Expense 10.09 14.60 31.76

10x Genomics Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Accounts Payable & Accrued Expense Premium Member Only Premium Member Only Premium Member Only 0.00 24.34 24.34 31.76 28.49

10x Genomics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


10x Genomics Accounts Payable & Accrued Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)